This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
kneat.com (KSI) 주식 개요
는 자회사와 함께 북미, 유럽 및 아시아 태평양 지역의 규제 환경 내에서 데이터 및 문서 관리를 위한 소프트웨어를 설계, 개발 및 공급합니다. 자세히 보기
KSI Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
kneat.com, inc. 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | CA$6.50 |
| 52주 최고가 | CA$6.50 |
| 52주 최저가 | CA$3.23 |
| 베타 | 1.33 |
| 1개월 변동 | 0.62% |
| 3개월 변동 | 27.70% |
| 1년 변동 | 13.04% |
| 3년 변동 | 119.59% |
| 5년 변동 | 71.05% |
| IPO 이후 변동 | 1,757.14% |
최근 뉴스 및 업데이트
내러티브 업데이트 • Jun 24
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.내러티브 업데이트 • Jun 07
KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.Recent updates
내러티브 업데이트 • Jun 24
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.내러티브 업데이트 • Jun 07
KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.내러티브 업데이트 • May 13
KSI: Life Sciences Validation Adoption And Special Committee Review Will Support Future Upside
Analysts have increased the fair value estimate for kneat.com from CA$5.70 to CA$5.90, aligning it with recent Street price target adjustments in the CA$5.50 to CA$6.25 range and reflecting views on the company's growth profile, margins and P/E expectations. Analyst Commentary Recent Street research around kneat.com has focused on recalibrating price targets while keeping positive ratings in place.내러티브 업데이트 • Apr 21
KSI: Pharma Packaging Agreements And Data Integrity Adoption Will Support Future Upside
Narrative Update Analysts have trimmed their blended price target on kneat.com by CA$1.00 to CA$5.50, reflecting recent target cuts from CA$6.50, while still citing supportive views on the business outlook. Analyst Commentary Recent research suggests that while price targets on kneat.com have been reset to CA$5.50, the general tone from covering firms still leans supportive, with ratings such as Buy and Outperformer maintained alongside a fresh, constructive initiation.내러티브 업데이트 • Apr 05
KSI: Global Pharma Agreements And Data Integrity Adoption Will Support Future Margin Expansion
Analysts have trimmed their average price target on kneat.com to CA$5.50 from CA$6.50, citing refreshed assumptions around discount rates, long term growth expectations and valuation multiples, while generally maintaining positive ratings on the shares. Analyst Commentary Recent research on kneat.com points to a reset in expectations, with price targets grouped around CA$5.50 and ratings that remain generally constructive on the company’s execution and growth potential.내러티브 업데이트 • Mar 21
KSI: Data Integrity Adoption And New Pharma Wins Will Support Future Margin Expansion
The analyst price target for kneat.com has been trimmed to CA$5.50 from CA$6.50. Analysts are factoring in an updated fair value of CA$5.70, a modestly higher discount rate, and adjusted revenue growth and profit margin assumptions, while still citing generally positive research commentary on the shares.내러티브 업데이트 • Mar 07
KSI: Data Integrity Adoption Will Support Future Margin Expansion Despite Reset Expectations
Analysts have reduced their fair value estimate for kneat.com to CA$5.75 from CA$6.67. This change reflects recent cuts to Street price targets to around CA$5.50 and more cautious assumptions on growth, margins, and future P/E.내러티브 업데이트 • Feb 20
KSI: Data Integrity Adoption Will Support Future Margin Expansion Potential
Analysts have maintained their CA$6.67 price target on kneat.com, citing supportive TD Securities research. The research highlights the company’s growth profile and long-term margin potential, as reflected in modest adjustments to the discount rate, revenue growth, and future P/E assumptions.내러티브 업데이트 • Feb 06
KSI: Global Validation Wins And Bullish Coverage Will Support Future Upside
Analysts have trimmed their price expectations for kneat.com, with recent targets moving from C$7.50 to C$5.50 and from C$8.50 to C$7.50. This reflects updated views on fair value, profitability assumptions and future P/E levels, while a new bullish initiation from TD Securities highlights ongoing interest in the name.내러티브 업데이트 • Jan 23
KSI: Global Validation Agreements Will Support Future Upside Despite Lowered Street Expectations
Narrative update on kneat.com The analyst price target for kneat.com has been revised lower to C$5.50 to C$7.50, down from C$7.50 to C$8.50, as analysts adjust their views while maintaining positive ratings on the shares. Analyst Commentary Recent research reflects a mixed but generally constructive stance on kneat.com, with both supporting and cautionary points tied to the revised price targets of C$5.50 and C$7.50 and the maintained positive ratings.내러티브 업데이트 • Jan 08
KSI: Global Validation Agreements Will Support Future Upside Despite Recent Estimate Revisions
Analysts nudged their fair value estimate for kneat.com to C$6.80 from C$6.60. Recent Street price target updates to C$5.50 and C$7.50 helped frame the new outlook on discount rates, revenue growth, profit margins and future P/E assumptions.내러티브 업데이트 • Dec 15
KSI: Expanding Global Validation Agreements Will Drive Future Outperformance
We lower our Kneat.com price target to C$5.50 from C$7.50, reflecting analysts' reduced near term expectations for valuation multiples, despite largely unchanged long term growth and margin assumptions. Analyst Commentary Recent Street research reflects a more tempered near term outlook for Kneat.com, with price targets revised lower but positive ratings maintained, signaling continued confidence in the company’s underlying growth trajectory.내러티브 업데이트 • Dec 01
KSI: Expansion Of Global Customer Agreements Will Drive Outperformance Ahead
Analysts have reduced their average price target for kneat.com from $6.80 to $6.60. This change is attributed to recent downward revisions to growth and profit forecasts.분석 기사 • Nov 18
Market Cool On kneat.com, inc.'s (TSE:KSI) Revenues Pushing Shares 26% Lower
The kneat.com, inc. ( TSE:KSI ) share price has fared very poorly over the last month, falling by a substantial 26...내러티브 업데이트 • Nov 17
KSI: Momentum In Securing New Customers Will Drive Performance Ahead
Analysts have lowered their price targets for kneat.com. Target estimates have decreased from C$8.50 and C$7.50 previously to updated levels of C$7.50 and C$5.50 respectively, citing slower expected revenue growth and a slightly higher discount rate as key factors in their revised outlook.
새로운 내러티브 • Mar 29
Life Sciences Wins And Expanded Sales Will Open Future Markets
Strategic wins and expansions in multiple sectors, alongside enhanced AI tools, are expected to boost revenue and improve net margins.분석 기사 • Mar 01
kneat.com, inc. (TSE:KSI) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for kneat.com, inc. ( TSE:KSI ) shareholders, with its shares surging 15% to CA$6.88 in...분석 기사 • Feb 22
A Look At The Intrinsic Value Of kneat.com, inc. (TSE:KSI)
Key Insights The projected fair value for kneat.com is CA$5.19 based on 2 Stage Free Cash Flow to Equity Current share...분석 기사 • May 11
Investors Still Waiting For A Pull Back In kneat.com, inc. (TSE:KSI)
With a price-to-sales (or "P/S") ratio of 10.1x kneat.com, inc. ( TSE:KSI ) may be sending very bearish signals at the...분석 기사 • Nov 08
Is kneat.com (TSE:KSI) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Aug 04
Here's Why We're Not Too Worried About kneat.com's (TSE:KSI) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...분석 기사 • Jun 30
Fewer Investors Than Expected Jumping On kneat.com, inc. (TSE:KSI)
There wouldn't be many who think kneat.com, inc.'s ( TSE:KSI ) price-to-sales (or "P/S") ratio of 8.7x is worth a...주주 수익률
| KSI | CA Healthcare Services | CA 시장 | |
|---|---|---|---|
| 7D | 0.3% | 0.4% | 1.0% |
| 1Y | 13.0% | -23.4% | 31.3% |
수익률 대 산업: KSI은 지난 1년 동안 -23.4%의 수익을 기록한 Canadian Healthcare Services 산업보다 더 좋은 성과를 냈습니다.
수익률 대 시장: KSI은 지난 1년 동안 31.3%를 기록한 Canadian 시장보다 저조한 성과를 냈습니다.
주가 변동성
| KSI volatility | |
|---|---|
| KSI Average Weekly Movement | 5.6% |
| Healthcare Services Industry Average Movement | 9.3% |
| Market Average Movement | 9.7% |
| 10% most volatile stocks in CA Market | 16.4% |
| 10% least volatile stocks in CA Market | 3.8% |
안정적인 주가: KSI는 지난 3개월 동안 Canadian 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: KSI의 주간 변동성(6%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 2007 | 343 | Eddie Ryan | kneat.com |
는 자회사와 함께 북미, 유럽 및 아시아 태평양 지역의 규제 환경 내에서 데이터 및 문서 관리를 위한 소프트웨어를 설계, 개발 및 공급합니다. 이 회사는 생명공학, 제약 및 의료 기기 제조 산업을 위한 검증 수명 주기 관리 및 테스트에 초점을 맞춘 구성 가능한 기성 애플리케이션인 Kneat Gx 플랫폼을 제공합니다. 이 플랫폼은 문서 관리, 분석 기기 검증, 방법 검증, 시운전 및 자격 검증, 도면 관리, 유틸리티 및 시설 검증, 콜드 체인 검증, 전자 기록부 관리, 프로세스 검증, 컴퓨터 시스템 검증, 세척 검증 등 다양한 애플리케이션에 사용됩니다.
kneat.com, inc. 기초 지표 요약
| KSI 기초 통계 | |
|---|---|
| 시가총액 | CA$626.99m |
| 순이익 (TTM) | -CA$8.44m |
| 매출 (TTM) | CA$66.52m |
9.5x
주가매출비율(P/S)-74.5x
주가수익비율(P/E)KSI는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| KSI 손익계산서 (TTM) | |
|---|---|
| 매출 | CA$66.52m |
| 매출원가 | CA$15.54m |
| 총이익 | CA$50.97m |
| 기타 비용 | CA$59.41m |
| 순이익 | -CA$8.44m |
최근 보고된 실적
Mar 31, 2026
다음 실적 발표일
해당 없음
| 주당순이익(EPS) | -0.087 |
| 총이익률 | 76.63% |
| 순이익률 | -12.69% |
| 부채/자본 비율 | 31.6% |
KSI의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/08/11 15:41 |
| 종가 | 2026/08/11 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
kneat.com, inc.는 9명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Gavin Fairweather | ATB Cormark |
| Douglas Taylor | Canaccord Genuity |
| Stephanie Price | CIBC Capital Markets |